Identifying new proteins that regulate cell transport processes
Official title: Discovery and characterization of a novel family of GTPase activating proteins
Funded at Cornell University · NIH-10995673 · Data updated 2026-11-12
This study is exploring a new group of proteins that help move things around inside our cells, and it's looking to find out how they work and what happens when they don't function properly, which could help develop better treatments for diseases.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cornell University NIH-funded |
| Lab location | 1 site (Ithaca, United States) |
| Project start | July 1, 2024 |
| Project end | June 30, 2026 |
| Funding year | 2024 |
| Award (this year) | $74,284 |
| NIH project number | 1F32GM155980-01 |
| Project ID | NIH-10995673 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals with conditions linked to cellular transport dysfunctions.
✕Less likely to help
Patients with diseases unrelated to cellular transport mechanisms may not benefit from this research.
What this research studies
This research investigates a new family of proteins that control how materials are transported within cells. By using advanced imaging techniques and genetic manipulation, the study aims to understand how these proteins function and their role in maintaining cellular health. The research will focus on identifying the specific targets of these proteins and how their misregulation can lead to diseases. Patients may benefit from insights gained about cellular transport mechanisms that could inform future therapies.
Why it matters
Potential benefit: If successful, this research could lead to new treatments for diseases caused by disruptions in cellular transport.
How similar studies have gone: Previous research has successfully identified and characterized similar proteins, suggesting a promising avenue for further exploration.
Where this research is happening
-
Cornell University
Ithaca, United States Active
Researchers
- Principal investigator: Vignogna, Ryan Christopher — Cornell University
- Study coordinator: Vignogna, Ryan Christopher
Related research
Other NIH-funded projects on the same topics.
-
PORTENT 3.0 Technical Core for global health point-of-care tools
A NIH U54 grant supports Cornell and partners in advancing point-of-care technologies for nutrition, infection, and cancer to real-world use, especially in global health settings.
-
Point-of-care zinc test strips to verify infant zinc medicines in low-resource settings
A fast, low-cost smartphone‑based test strips method checks zinc-containing infant medicines in places with limited lab access.
-
Center for Spillover Prevention and One Health Readiness in Asia
A center in Asia works to prevent pandemics by studying how animal infections jump to humans and by building tools to detect and respond quickly to spillovers.
-
SAGE: A privacy-friendly system to monitor antimicrobial use in animals
A nationwide, privacy-preserving data hub will securely collect and standardize antimicrobial use data across animal species to support smarter stewardship and regulatory science.
-
Rapid, bedside KS diagnosis in Africa with KS-COMPLETE
A fast, point-of-care test using skin biopsies to diagnose Kaposi’s sarcoma in sub-Saharan Africa, helping patients get results in about an hour.
-
Nuclear mechanics in tight cell movement
Scientists are studying how the nucleus changes its shape and function when cells squeeze through very small spaces, which could affect health and disease.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.